Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

13.05.2024

1 Am J Pathol
1 BMC Cancer
3 BMC Gastroenterol
1 Br J Surg
1 Cancer Res
7 Clin Res Hepatol Gastroenterol
1 Dig Dis Sci
2 Indian J Gastroenterol
1 J Gastroenterol
2 J Gastroenterol Hepatol
2 J Hepatol
1 PLoS Med
5 PLoS One
1 Radiology
1 Transplantation



    Am J Pathol

  1. MARTUCCI NJ, Stoops J, Bowen W, Orr A, et al
    A novel role for the phosphatidylinositol-4,5-bisphosphate 3-kinase delta isoform in hepatocellular proliferation.
    Am J Pathol. 2024 May 3:S0002-9440(24)00168-8. doi: 10.1016/j.ajpath.2024.
    >> Share


    BMC Cancer

  2. WEI G, Zhao Y, Feng S, Yuan J, et al
    Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    BMC Cancer. 2024;24:558.
    >> Share


    BMC Gastroenterol

  3. KOLAWOLE OJ, Oje MM, Betiku OA, Ijarotimi O, et al
    Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria.
    BMC Gastroenterol. 2024;24:147.
    >> Share

  4. HOSSEINI SA, Shayesteh AA, Hashemi SJ, Rahimi Z, et al
    The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease.
    BMC Gastroenterol. 2024;24:159.
    >> Share

  5. XU X, Gong K, Hong L, Yu X, et al
    The burden and predictors of 30-day unplanned readmission in patients with acute liver failure: a national representative database study.
    BMC Gastroenterol. 2024;24:153.
    >> Share


    Br J Surg

  6. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    >> Share


    Cancer Res

  7. HE W, Wang M, Zhang X, Wang Y, et al
    Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development.
    Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-3966.
    >> Share


    Clin Res Hepatol Gastroenterol

  8. ABBASSI N, Bourrahouat A, Bedoya EC, Pagan C, et al
    Phenotype and molecular characterization of Wilson's disease in Morocco.
    Clin Res Hepatol Gastroenterol. 2024;48:102335.
    >> Share

  9. ZHU X, Zeng C, Yu B
    White adipose tissue in metabolic associated fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102336.
    >> Share

  10. PATEL K, Twohig P, Peeraphatdit T, Stohs EJ, et al
    Outcomes and factors associated with cryptococcal disease among cirrhotics: A study of the national inpatient sample 2005 to 2014.
    Clin Res Hepatol Gastroenterol. 2024;48:102337.
    >> Share

  11. WONG SH, Ng HI, Liu Y, Yu HH, et al
    Endoscopic submucosal dissection for early esophageal squamous cell carcinoma after ligation and sclerotherapy of esophageal and gastric varices.
    Clin Res Hepatol Gastroenterol. 2024;48:102339.
    >> Share

  12. FULBERT M, El Amrani M, Baillet C, Lecolle K, et al
    Sarcopenia does not affect liver regeneration and postoperative course after a major hepatectomy. A prospective study on 125 patients using CT volumetry and HIDA scintigraphy.
    Clin Res Hepatol Gastroenterol. 2024;48:102332.
    >> Share

  13. LI R, Sarin S
    The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020.
    Clin Res Hepatol Gastroenterol. 2024;48:102323.
    >> Share

  14. LIANG Y, Li J, Zhang Z, Jiang T, et al
    Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk.
    Clin Res Hepatol Gastroenterol. 2024;48:102321.
    >> Share


    Dig Dis Sci

  15. UFERE NN
    Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology.
    Dig Dis Sci. 2024 May 4. doi: 10.1007/s10620-024-08406.
    >> Share


    Indian J Gastroenterol

  16. BALARAJA S, Shastri A, Chaluvashetty SB, De A, et al
    Post cholecystectomy cysto-hepatic duct stricture.
    Indian J Gastroenterol. 2024 May 9. doi: 10.1007/s12664-024-01598.
    >> Share

  17. KHANNA D, Kar P, Sahu P
    Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis.
    Indian J Gastroenterol. 2024 May 9. doi: 10.1007/s12664-024-01566.
    >> Share


    J Gastroenterol

  18. ATSUKAWA M, Tsubota A, Kondo C, Toyoda H, et al
    ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.
    J Gastroenterol. 2024 May 10. doi: 10.1007/s00535-024-02109.
    >> Share


    J Gastroenterol Hepatol

  19. LEE J, Jin YJ, Shin SK, Kwon JH, et al
    Clinical outcomes of transarterial chemoembolization in Child-Turcotte Pugh class A patients with a single small (
    J Gastroenterol Hepatol. 2024 May 6. doi: 10.1111/jgh.16581.
    >> Share

  20. LIM J, Kim JH, Kim SE, Han SK, et al
    Validation of MELD 3.0 in patients with alcoholic liver cirrhosis using prospective KACLiF cohort.
    J Gastroenterol Hepatol. 2024 May 8. doi: 10.1111/jgh.16591.
    >> Share


    J Hepatol

  21. ZHU B, Guo Y, Lv S, Ling X, et al
    Hepatic phenotypes of EFL1-related Shwachman-Diamond syndrome in a biopsy-validated study.

    J Hepatol. 2024 May 3:S0168-8278(24)00328-3. doi: 10.1016/j.jhep.2024.
    >> Share

  22. HARRISON SA, Rolph T, Knot M, Dubourg J, et al
    FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond.
    J Hepatol. 2024 May 4:S0168-8278(24)00332-5. doi: 10.1016/j.jhep.2024.
    >> Share


    PLoS Med

  23. WANG DS, Ren C, Li SS, Fong WP, et al
    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
    PLoS Med. 2024;21:e1004389.
    >> Share


    PLoS One

  24. GALIERO R, Loffredo G, Simeon V, Caturano A, et al
    Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.
    PLoS One. 2024;19:e0296495.
    >> Share

  25. FUNUYET-SALAS J, Martin-Rodriguez A, Perez-San-Gregorio MA, Vale L, et al
    Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom.
    PLoS One. 2024;19:e0300362.
    >> Share

  26. YUAN C, Li W, Liu J, Li J, et al
    Frailty and transplant-free survival of patients with liver cirrhosis: A meta-analysis.
    PLoS One. 2024;19:e0302836.
    >> Share

  27. TABACU L, Swami S, Ledbetter M, Siddiqui MS, et al
    Socioeconomic status and health disparities drive differences in accelerometer-derived physical activity in fatty liver disease and significant fibrosis.
    PLoS One. 2024;19:e0301774.
    >> Share

  28. PAN Z, Bayoumi A, Metwally M, George J, et al
    Exportin 4 DNA promoter methylation in liver fibrosis.
    PLoS One. 2024;19:e0302786.
    >> Share


    Radiology

  29. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    >> Share


    Transplantation

  30. ZHAN M, Liu D, Yao L, Wang W, et al
    Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.
    Transplantation. 2024 May 10. doi: 10.1097/TP.0000000000005036.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016